Nissay Asset Management Corp Japan ADV Trims Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Nissay Asset Management Corp Japan ADV reduced its stake in IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 79.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 22,247 shares of the medical research company's stock after selling 85,982 shares during the quarter. Nissay Asset Management Corp Japan ADV's holdings in IQVIA were worth $4,436,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Synergy Asset Management LLC purchased a new position in IQVIA during the fourth quarter worth about $33,000. GKV Capital Management Co. Inc. purchased a new position in IQVIA during the fourth quarter worth about $39,000. Lee Danner & Bass Inc. purchased a new position in IQVIA during the fourth quarter worth about $44,000. Zions Bancorporation N.A. lifted its position in IQVIA by 55.2% during the fourth quarter. Zions Bancorporation N.A. now owns 239 shares of the medical research company's stock worth $47,000 after buying an additional 85 shares during the period. Finally, SBI Securities Co. Ltd. purchased a new position in IQVIA during the fourth quarter worth about $60,000. 89.62% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on IQV shares. JPMorgan Chase & Co. reduced their target price on IQVIA from $240.00 to $232.00 and set an "overweight" rating on the stock in a research report on Tuesday, February 18th. Royal Bank of Canada restated an "outperform" rating and issued a $270.00 price objective on shares of IQVIA in a report on Monday, February 10th. Mizuho cut their price objective on IQVIA from $210.00 to $190.00 and set an "outperform" rating on the stock in a report on Thursday. Truist Financial cut their price objective on IQVIA from $263.00 to $216.00 and set a "buy" rating on the stock in a report on Thursday, April 10th. Finally, StockNews.com downgraded IQVIA from a "buy" rating to a "hold" rating in a report on Wednesday, March 12th. Eight investment analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, IQVIA has a consensus rating of "Moderate Buy" and a consensus price target of $230.76.

IQVIA Price Performance

Shares of NYSE IQV opened at $142.66 on Friday. IQVIA Holdings Inc. has a fifty-two week low of $135.97 and a fifty-two week high of $252.88. The business has a 50 day moving average price of $159.83 and a two-hundred day moving average price of $186.07. The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 2.12. The firm has a market cap of $24.68 billion, a PE ratio of 19.02, a price-to-earnings-growth ratio of 1.99 and a beta of 1.34.

IQVIA (NYSE:IQV - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The medical research company reported $2.70 earnings per share for the quarter, beating analysts' consensus estimates of $2.63 by $0.07. IQVIA had a return on equity of 28.81% and a net margin of 8.91%. The firm had revenue of $3.83 billion during the quarter, compared to analyst estimates of $3.77 billion. During the same quarter last year, the firm earned $2.54 EPS. IQVIA's quarterly revenue was up 2.5% on a year-over-year basis. Sell-side analysts expect that IQVIA Holdings Inc. will post 10.84 earnings per share for the current fiscal year.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IQVIA Holdings Inc. (NYSE:IQV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.